Table 3 Performance of SCCA, POU3F3 and both SCCA and POU3F3 in the detection of different clinical stage ESCC
| Â | Clinical stage | P (Pearson Chi-square) | ||||
|---|---|---|---|---|---|---|
I | II | III | IV | Total | ||
SCCA | 26% (7/26) | 35.9% (14/39) | 76.4% (39/51) | 87.1% (27/31) | 59.2% (87/147) | 0.000 |
POU3F3 | 69.2% (18/26) | 66.6% (26/39) | 78.4% (40/51) | 74.2% (23/31) | 72.8% (107/147) | 0.455 |
SCCA + POU3F3 | 80.8% (21/26) | 76.9% (30/39) | 90.2% (46/51) | 93.5% (29/31) | 85.7% (126/147) | 0.147 |
P (combination vs. SCCA) | 0.000 | 0.001 | 0.109 | 0.671 | 0.000 | Â |